Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:911-916
Published online before print January 20, 2003, doi: 10.1161/01.CIR.0000048191.75585.60
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/6/911    most recent
01.CIR.0000048191.75585.60v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Visner, G. A.
Right arrow Articles by Agarwal, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Visner, G. A.
Right arrow Articles by Agarwal, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Transplantation
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2003;107:911.)
© 2003 American Heart Association, Inc.


Basic Science Reports

Rapamycin Induces Heme Oxygenase-1 in Human Pulmonary Vascular Cells

Implications in the Antiproliferative Response to Rapamycin

Gary A. Visner, DO; Fuhua Lu, PhD; Hailan Zhou, PhD; Jun Liu, MS; Kristy Kazemfar, BS; Anupam Agarwal, MD

From the Departments of Pediatrics (G.A.V., F.L., H.Z., J.L., K.K.) and Medicine (A.A.), College of Medicine, University of Florida, Gainesville.

Correspondence to Dr Gary A. Visner, Department of Pediatrics, University of Florida, Box 100296, 1600 SW Archer, Gainesville, FL 32610. E-mail visnega{at}peds.ufl.edu

Background— Rapamycin is an immunosuppressive agent with antiproliferative properties against not only lymphocytes but also vascular endothelial and smooth muscle cells, and it reduces the fibroproliferative response to vascular injury. Heme oxygenase-1 (HO-1) has also been shown to have graft protective effects and to inhibit vascular remodeling. In this study, we evaluated whether there is an interaction between rapamycin and HO-1.

Methods and Results— In human pulmonary artery endothelial or smooth muscle cells, HO-1 expression was evaluated in response to rapamycin or wortmannin, an inhibitor of the upstream modulator of mammalian target of rapamycin (mTOR) PI-3K. We also evaluated whether the inhibitory actions of rapamycin on platelet-derived growth factor–dependent proliferation was mediated by HO using the chemical inhibitor tin protoporphyrin. Rapamycin induced HO-1 expression in both pulmonary endothelial and smooth muscle cells, whereas no to little increase was seen in response to another immunosuppressive agent, cyclosporin A. HO-1 expression was also increased in response to wortmannin, suggesting that the PI-3K–mTOR pathway is required for this induction. Inhibition of HO activity resulted in a loss of the antiproliferative activity of rapamycin in growth factor–stimulated smooth muscle cells.

Conclusions— The induction of HO-1 expression by rapamycin and, more importantly, the effects of tin protoporphyrin, an inhibitor of HO activity, on the antiproliferative actions of rapamycin suggest that the effects of rapamycin may be, at least in part, modulated by its actions on HO-1.


Key Words: heme oxygenase • sirolimus • wortmannin • cells, endothelial • cells, muscle, smooth




This article has been cited by other articles:


Home page
BloodHome page
H. Matsushima, H. Tanaka, N. Mizumoto, and A. Takashima
Identification of crassin acetate as a new immunosuppressant triggering heme oxygenase-1 expression in dendritic cells
Blood, July 2, 2009; 114(1): 64 - 73.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. R. Kinderlerer, I. Pombo Gregoire, S. S. Hamdulay, F. Ali, R. Steinberg, G. Silva, N. Ali, B. Wang, D. O. Haskard, M. P. Soares, et al.
Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin
Blood, February 12, 2009; 113(7): 1598 - 1607.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. G. Abraham and A. Kappas
Pharmacological and Clinical Aspects of Heme Oxygenase
Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Dulak, J. Deshane, A. Jozkowicz, and A. Agarwal
Heme Oxygenase-1 and Carbon Monoxide in Vascular Pathobiology: Focus on Angiogenesis
Circulation, January 15, 2008; 117(2): 231 - 241.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Hill-Kapturczak and A. Agarwal
Haem oxygenase-1--a culprit in vascular and renal damage?
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1495 - 1499.
[Full Text] [PDF]


Home page
CirculationHome page
R. Stocker and M. A. Perrella
Heme Oxygenase-1: A Novel Drug Target for Atherosclerotic Diseases?
Circulation, November 14, 2006; 114(20): 2178 - 2189.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Morita
Heme Oxygenase and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1786 - 1795.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. H. Bach
Heme oxygenase-1: a therapeutic amplification funnel
FASEB J, August 1, 2005; 19(10): 1216 - 1219.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Li, K. Tanaka, K. Morioka, T. Uesaka, N. Yamada, A. Takamori, M. Handa, S. Tanabe, and A. Ihaya
Thymidine Phosphorylase Gene Transfer Inhibits Vascular Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1 and p27KIP1
Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1370 - 1375.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Chen, M. H. Kapturczak, C. Wasserfall, O. Y. Glushakova, M. Campbell-Thompson, J. S. Deshane, R. Joseph, P. E. Cruz, W. W. Hauswirth, K. M. Madsen, et al.
Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway
PNAS, May 17, 2005; 102(20): 7251 - 7256.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y.-M. Deng, B. J. Wu, P. K. Witting, and R. Stocker
Probucol Protects Against Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1
Circulation, September 28, 2004; 110(13): 1855 - 1860.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Bussolati, A. Ahmed, H. Pemberton, R. C. Landis, F. Di Carlo, D. O. Haskard, and J. C. Mason
Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration
Blood, February 1, 2004; 103(3): 761 - 766.
[Abstract] [Full Text] [PDF]